What stage does QVT invest at?

QVT invests at Pre-Seed, Seed stages.

What check size does QVT write?

InvestorMatch does not have a recorded check size for QVT. Its stage focus (Pre-Seed, Seed) is the best available signal for round size.

What sectors does QVT invest in?

QVT invests in Climate / Energy.

How much capital does QVT manage?

QVT manages approximately $1B in assets under management.

QVT — Pre-Seed & Seed VC Firm

Q: Who are the partners at QVT?

Partners at QVT include Victor Kaiser-Pendergrast (Chief Operating Officer), Michael Coursen (Chief Accounting Officer), Priyanka Trisal (Director of Operations), Warren Beetar (Director of Operations).

Q: What has QVT invested in recently?

QVT has 5+ portfolio companies, including Pharmasset, Medivation, Roivant Sciences Ltd, QuEra Computing, Biosynexus.

Profile updated October 2026Website

QVT is a Pre-Seed, Seed venture capital firm investing in Climate / Energy. The firm has 5 portfolio companies in our records.

Portfolio: 5 companies on record
Partners: 4 listed
AUM: $1B
Stage: Pre-Seed, Seed
Sectors: Climate / Energy
Check size: Not in our records

Last verified: 2026-10-26

How to approach: warm intro preferred

Stage

Pre-Seed, Seed

AUM

$1.0B

Portfolio

5+ companies

Team

4 partners

Investment Thesis

Investor participating in climate and materials-oriented pre-seed rounds, including solar technology.

How QVT invests

QVT is a vc firm. The firm invests at the Pre-Seed, Seed stages, with a focus on Climate / Energy.

QVT manages approximately $1B in assets. Our records include 6 funds raised by the firm.

QVT has backed 5 companies in our records, including Pharmasset, Medivation, Roivant Sciences Ltd.

Partners & Team

Victor Kaiser-Pendergrast

Chief Operating Officer

Michael Coursen

Chief Accounting Officer

Priyanka Trisal

Director of Operations

Warren Beetar

Director of Operations

Industry Focus

Invests In

Climate / Energy

Funds

QVT Fund VI

$400M2022

investing

QVT Fund V

$350M2019

closed

QVT Fund IV

$300M2016

closed

QVT Fund III

$250M2013

closed

QVT Fund II

$200M2010

closed

QVT Fund I

$150M2007

closed

Recent Activity

Raised QVT Fund VI ($400M)

2022 · fund records

Raised QVT Fund V ($350M)

2019 · fund records

Raised QVT Fund IV ($300M)

2016 · fund records

Raised QVT Fund III ($250M)

2013 · fund records

Raised QVT Fund II ($200M)

2010 · fund records

Raised QVT Fund I ($150M)

2007 · fund records

Portfolio Companies (5)

Other

Pharmasset

biopharmaceutical company focused on antiviral drugs

Medivation

biopharmaceutical company focused on oncology therapies

Roivant Sciences Ltd

biopharmaceutical company that develops and commercializes medicines through subsidiaries

QuEra Computing

quantum computing / deep tech·late-stage growth/venture·QVT Family Office / QVT funds

neutral-atom quantum computing company building large-scale fault-tolerant quantum computers

Biosynexus

biotech / pharma·private company acquisition / growth-stage biotech·QVT Fund LP

biotechnology-pharmaceutical company developing products for prevention and treatment of infectious diseases

How to pitch QVT

•Raising at Pre-Seed, Seed? You're squarely in their sweet spot.
•Lead with your fit in Climate / Energy — the sectors they actively back.
•warm intro preferred
•Address your outreach to a specific partner, such as Victor Kaiser-Pendergrast, Chief Operating Officer.
•A warm introduction beats a cold email. Get matched and request an intro.